|
PNP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14050008221045E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.21710016801558E-10 |
| Normal-vs-Stage2 |
3.0029978503876E-11 |
| Normal-vs-Stage3 |
3.25950000323871E-09 |
| Normal-vs-Stage4 |
6.74880151763091E-11 |
| Stage1-vs-Stage2 |
1.187370E-01 |
| Stage1-vs-Stage3 |
9.226000E-01 |
| Stage1-vs-Stage4 |
1.350630E-01 |
| Stage2-vs-Stage3 |
1.424770E-01 |
| Stage2-vs-Stage4 |
6.669200E-01 |
| Stage3-vs-Stage4 |
8.134200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27040053424332E-10 |
| Normal-vs-AfricanAmerican |
5.967799587836E-10 |
| Normal-vs-Asian |
1.083170E-03 |
| Caucasian-vs-AfricanAmerican |
3.343400E-01 |
| Caucasian-vs-Asian |
7.822600E-01 |
| AfricanAmerican-vs-Asian |
9.551200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.74610001405051E-10 |
| Normal-vs-Female |
4.77360040385122E-10 |
| Male-vs-Female |
4.065400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.48460182720123E-11 |
| Normal-vs-Extreme_Weight |
1.36559985541851E-10 |
| Normal-vs-Obese |
6.854800060907E-10 |
| Normal-vs-Extreme_Obese |
1.993380E-04 |
| Normal_Weight-vs-Extreme_Weight |
7.304800E-01 |
| Normal_Weight-vs-Obese |
2.338200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.580150E-01 |
| Extreme_Weight-vs-Obese |
2.769400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.193200E-01 |
| Obese-vs-Extreme_Obese |
5.103600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.27250000001322E-06 |
| Normal-vs-Age(41-60Yrs) |
4.40069980456315E-10 |
| Normal-vs-Age(61-80Yrs) |
1.78649983695323E-10 |
| Normal-vs-Age(81-100Yrs) |
1.73620007259956E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.695600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.522200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.442800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.240800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.156000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.133400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.15099970957544E-10 |
| Normal-VS-Type2 PRCC |
2.97859958919844E-10 |
| Normal-VS-KIRP CIMP |
3.04909997250746E-09 |
| Normal-VS-Unclassified PRCC |
3.40479866522969E-11 |
| Type1 PRCC-VS-Type2 PRCC |
6.666600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.142200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.544400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.761800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.048400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.446600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.42139649944784E-11 |
| Normal-vs-N1 |
9.16400288986097E-11 |
| Normal-vs-N2 |
2.646400E-04 |
| N0-vs-N1 |
9.259000E-01 |
| N0-vs-N2 |
1.565390E-01 |
| N1-vs-N2 |
1.810010E-01 |
|
|
